MenopauseNCT06048965
Asia Pacific Menopause Federation Menopause Consensus
An observational study of Menopause and Menopause Related Conditions, run by Singapore General Hospital at 1 site in Singapore.
Trial summary
The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific Read more about this study
- Who is it for?
- Ages 21 years and olderHealthy volunteers can take part
- Conditions the study is for
- Menopause, Menopause Related Conditions
- How many people
- 100 participants
- Where
- 1 siteSingapore
- Study dates
- 20 Nov 2023to 15 Mar 2025
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Physicians with experience in treating menopause
Who may be able to join
- Experience in treating menopause
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
Singapore1 site, 1 recruiting
- Recruiting
Singapore General Hospital
Singapore
Felicia C Tan, MBBChir
About this study
Official title: An Expert Panel Consensus Statement on the Management of Menopause in the Asia-Pacific Using Modified Delphi Methodology
The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific
Read the detailed description
The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific. The experience of the menopause is deeply rooted in sociocultural perceptions unique to each population. Thus, the management of menopausal symptoms and other conditions related to the menopause also vary from region to region.
The investigators will use a modified Delphi method involving the participation of experts from various countries in the Asia-Pacific. The objective of this study is to achieve consensus on various aspects of the management of the menopause in the Asia-Pacific.
This study will involve several rounds of Delphi surveys, administered via Google Forms, Microsoft Word or PDF. Each survey questionnaire contains
- Questions on basic demographic information
- Statements on areas of concern in the management of the menopause; each participants vote on to what extent they agree or disagree with the statement on a Likert scale.
- Questions on the participants' usual clinical practice in treating menopause Multiple survey rounds will be held until agreement on the statements and stability is achieved.
- Conditions
- Menopause, Menopause Related Conditions
- Being tested
- No intervention to be performed
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No intervention to be performedOther
No intervention to be performed. Anonymous survey only.
| Study group | Role | What they receive |
|---|---|---|
| Expert group | Not described Receives: Other: No intervention to be performed |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of participants who vote for the same option on a series of survey questions
Measured: 2023-2024
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Sep 2023
- Study start20 Nov 2023 (estimated)
- Primary completion15 Sep 2024 (estimated)
- Study completion15 Mar 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MenopauseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Singapore General Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06048965
- Sponsor's protocol ID
- APMFMenopause2023
- Status last verified
- Nov 2023
- First submitted
- 29 Aug 2023
- Last updated
- 8 Nov 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No